● AI Equity Research · Healthcare

Teladoc Health, Inc. (TDOC)

AI stock analysis · Health Information Services · Last analyzed Aug 17, 2026

Compass Score

2.0/5

Call

Hold

Price

$6.81

AI Target

$7.74 +13.6%

AI Analyst Summary

Teladoc Health is a telehealth pioneer navigating a difficult post-pandemic normalization, with revenue declining -4.0% YoY and the company remaining unprofitable — core structural challenges that weigh heavily on the investment case. On the positive side, management has beaten EPS estimates in each of the last 4 reported quarters, signaling improving cost control even as top-line growth stalls. The primary risk is the company's inability to return to revenue growth or profitability in a competitive telehealth landscape, which limits meaningful upside to the modest 13.7% implied by the analyst consensus target.

Catalysts

Potential return to revenue growth in H2 2025 driven by BetterHelp segment stabilization and enterprise client expansions, which could shift the analyst consensus from Hold toward Buy.
Continued operating expense reduction initiatives that could accelerate the path to GAAP profitability, a key re-rating catalyst given the current loss-making status.
Strategic partnership announcements or M&A activity within the health information services space that could unlock synergies and reignite investor interest in the platform.

Risks

Sustained revenue contraction: a -4.0% YoY decline could worsen if BetterHelp user attrition continues, directly threatening the company's path to breakeven.
Competitive pressure from Amazon Clinic, CVS Health, and other scaled telehealth entrants compressing pricing and market share in Teladoc's core virtual care segments.
Balance sheet risk from ongoing cash burn in a loss-making state; prolonged unprofitability could necessitate dilutive capital raises, pressuring the already-depressed share price near $6.81.

Fundamentals

Pe N/A (loss-making) · 1.0/5

No trailing P/E available; company is not profitable. Forward P/E of -8.7x reflects ongoing losses with no near-term path to positive earnings, a significant red flag for valuation.

Peg N/A · 2.0/5

PEG ratio is unavailable due to negative earnings. Revenue is declining -4.0% YoY, which further undermines any growth-adjusted valuation argument, warranting a below-average score.

Analyst Rating Hold (2.5) · 3.0/5

Consensus sits exactly at the Hold boundary (2.5) with 19 analysts covered — 6 Buy, 18 Hold, 0 Sell. Sentiment is tepid; no strong conviction on either side, capped at 3 per the 2.5–3.0 mapping.

Earnings Trend Revenue declining -4.0% YoY; EPS N/A · 2.0/5

Revenue contraction of -4.0% YoY with no positive earnings trajectory is a meaningful headwind. The company is still loss-making with no reported YoY earnings growth, indicating a deteriorating fundamental trend.

Price Target Beat 4 of 4 quarters (EPS beats) · 3.0/5

A perfect 4-of-4 EPS beat rate over the last four quarters is encouraging, but the short window (only 4 quarters of data vs. the preferred 8) limits the score to 3 per guidelines for insufficient history.

Management Mixed — consistent EPS beats offset by revenue decline · 3.0/5

Management has delivered consistent EPS beats, suggesting some cost discipline, but the ongoing revenue contraction and inability to return to profitability temper confidence in strategic execution. Analyst sentiment is neutral.

● See the full picture

Get today's top-scored picks, ranked for you.

Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.

Start free for 3 days →

No credit card. Then $9/month. Cancel anytime.

How Compass scores stocks

Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →

Not financial advice. Compass is an analytical tool, not a registered investment adviser or broker-dealer. Scores and recommendations are generated by AI, may be inaccurate or out of date, and are not investment, financial, legal, or tax advice. Investing involves risk, including loss of principal. Do your own research and consult a licensed financial professional. About Compass.